145 related articles for article (PubMed ID: 36202066)
1. Dual MVK cleavable linkers effectively reduce renal retention of
Valpreda G; Trachsel B; Vogel V; Schibli R; Mu L; Behe M
Bioorg Med Chem; 2022 Nov; 73():117040. PubMed ID: 36202066
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of Met-Val-Lys as a Renal Brush Border Enzyme-Cleavable Linker to Reduce Kidney Uptake of
Bendre S; Zhang Z; Kuo HT; Rousseau J; Zhang C; Merkens H; Roxin Á; Bénard F; Lin KS
Molecules; 2020 Aug; 25(17):. PubMed ID: 32854201
[TBL] [Abstract][Full Text] [Related]
3. Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK.
Trachsel B; Valpreda G; Lutz A; Schibli R; Mu L; Béhé M
EJNMMI Radiopharm Chem; 2023 Sep; 8(1):21. PubMed ID: 37665477
[TBL] [Abstract][Full Text] [Related]
4. Improving the Theranostic Potential of Exendin 4 by Reducing the Renal Radioactivity through Brush Border Membrane Enzyme-Mediated Degradation.
Zhang M; Jacobson O; Kiesewetter DO; Ma Y; Wang Z; Lang L; Tang L; Kang F; Deng H; Yang W; Niu G; Wang J; Chen X
Bioconjug Chem; 2019 Jun; 30(6):1745-1753. PubMed ID: 31181890
[TBL] [Abstract][Full Text] [Related]
5. First-in-human validation of enzymolysis clearance strategy for decreasing renal radioactivity using modified [
Zhang M; Kang F; Xing T; Wang J; Ma T; Li G; Quan Z; Yang W; Chen X; Wang J
Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1713-1724. PubMed ID: 38216779
[TBL] [Abstract][Full Text] [Related]
6. A Gallium-67/68-Labeled Antibody Fragment for Immuno-SPECT/PET Shows Low Renal Radioactivity Without Loss of Tumor Uptake.
Uehara T; Yokoyama M; Suzuki H; Hanaoka H; Arano Y
Clin Cancer Res; 2018 Jul; 24(14):3309-3316. PubMed ID: 29666303
[No Abstract] [Full Text] [Related]
7. Brush border enzyme-cleavable linkers: Evaluation for reducing renal uptake of radiolabeled prostate-specific membrane antigen inhibitors.
Vaidyanathan G; Kang CM; McDougald D; Minn I; Brummet M; Pomper MG; Zalutsky MR
Nucl Med Biol; 2018; 62-63():18-30. PubMed ID: 29803076
[TBL] [Abstract][Full Text] [Related]
8. Copper-64-Labeled Antibody Fragments for Immuno-PET/Radioimmunotherapy with Low Renal Radioactivity Levels and Amplified Tumor-Kidney Ratios.
Suzuki H; Kise S; Kaizuka Y; Watanabe R; Sugawa T; Furukawa T; Fujii H; Uehara T
ACS Omega; 2021 Aug; 6(33):21556-21562. PubMed ID: 34471758
[TBL] [Abstract][Full Text] [Related]
9. Combined Probe Strategy to Increase the Enzymatic Digestion Rate and Accelerate the Renal Radioactivity Clearance of Peptide Radiotracers.
Zhang M; Ye J; Xie Z; Wang Y; Ma W; Kang F; Yang W; Wang J; Chen X
Mol Pharm; 2022 May; 19(5):1548-1556. PubMed ID: 35357154
[TBL] [Abstract][Full Text] [Related]
10. Reagents for astatination of biomolecules. 5. Evaluation of hydrazone linkers in (211)At- and (125)I-labeled closo-decaborate(2-) conjugates of Fab' as a means of decreasing kidney retention.
Wilbur DS; Chyan MK; Hamlin DK; Nguyen H; Vessella RL
Bioconjug Chem; 2011 Jun; 22(6):1089-102. PubMed ID: 21513347
[TBL] [Abstract][Full Text] [Related]
11. Labeling a TCO-functionalized single domain antibody fragment with
Zhou Z; Zalutsky MR; Vaidyanathan G
Bioorg Med Chem; 2020 Sep; 28(17):115634. PubMed ID: 32773089
[TBL] [Abstract][Full Text] [Related]
12. Optimization of Enzymolysis Clearance Strategy To Enhance Renal Clearance of Radioligands.
Zhang M; Ye J; Xie Z; Yan Y; Wang J; Chen X
Bioconjug Chem; 2021 Sep; 32(9):2108-2116. PubMed ID: 34486879
[TBL] [Abstract][Full Text] [Related]
13. (67/68)Ga-labeling agent that liberates (67/68)Ga-NOTA-methionine by lysosomal proteolysis of parental low molecular weight polypeptides to reduce renal radioactivity levels.
Uehara T; Rokugawa T; Kinoshita M; Nemoto S; Fransisco Lazaro GG; Hanaoka H; Arano Y
Bioconjug Chem; 2014 Nov; 25(11):2038-45. PubMed ID: 25303645
[TBL] [Abstract][Full Text] [Related]
14. Renal Handling of
Uehara T; Kanazawa N; Suzuki C; Mizuno Y; Suzuki H; Hanaoka H; Arano Y
Bioconjug Chem; 2020 Nov; 31(11):2618-2627. PubMed ID: 33085454
[TBL] [Abstract][Full Text] [Related]
15. Reduction of renal activity retention of radiolabeled albumin binding domain‑derived affinity proteins using a non‑residualizing label strategy compared with a cleavable glycine‑leucine‑glycine‑lysine‑linker.
Lundmark F; Vorobyeva A; Liu Y; Lindbo S; Xu T; Oroujeni M; Rinne SS; Rosenström U; Garousi J
Mol Med Rep; 2024 Feb; 29(2):. PubMed ID: 38186305
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of ¹¹¹in-labelled exendin-4 derivatives containing different meprin β-specific cleavable linkers.
Jodal A; Pape F; Becker-Pauly C; Maas O; Schibli R; Béhé M
PLoS One; 2015; 10(4):e0123443. PubMed ID: 25855967
[TBL] [Abstract][Full Text] [Related]
17. An Efficient Method for Labeling Single Domain Antibody Fragments with
Zhou Z; Devoogdt N; Zalutsky MR; Vaidyanathan G
Bioconjug Chem; 2018 Dec; 29(12):4090-4103. PubMed ID: 30384599
[TBL] [Abstract][Full Text] [Related]
18. Novel peptide probes to assess the tensional state of fibronectin fibers in cancer.
Arnoldini S; Moscaroli A; Chabria M; Hilbert M; Hertig S; Schibli R; Béhé M; Vogel V
Nat Commun; 2017 Nov; 8(1):1793. PubMed ID: 29176724
[TBL] [Abstract][Full Text] [Related]
19. Preferential Cleavage of a Tripeptide Linkage by Enzymes on Renal Brush Border Membrane To Reduce Renal Radioactivity Levels of Radiolabeled Antibody Fragments.
Suzuki C; Uehara T; Kanazawa N; Wada S; Suzuki H; Arano Y
J Med Chem; 2018 Jun; 61(12):5257-5268. PubMed ID: 29869881
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and radiolabelling of PSMA-targeted derivatives containing GYK/MVK cleavable linkers.
Murce E; de Blois E; van den Berg S; de Jong M; Seimbille Y
R Soc Open Sci; 2023 Mar; 10(3):220950. PubMed ID: 36908985
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
